Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W R Kirkpatrick

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
Journal of Clinical Microbiology|July 1, 1996
Simple method for detecting fluconazole-resistant yeasts with chromogenic agarT F Patterson, S G Revankar, W R Kirkpatrick, et al.
The Journal of Infectious Diseases|October 1, 1996
Detection and significance of fluconazole resistance in oropharyngeal candidiasis in human immunodeficiency virus-infected patientsS G Revankar, W R Kirkpatrick, R K McAtee, et al.
Journal of Clinical Microbiology|December 8, 2004
Comparison of antifungal susceptibilities to fluconazole and voriconazole of oral Candida glabrata isolates from head and neck radiation patientsA K Burn, A W Fothergill, W R Kirkpatrick, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 13, 1998
Clinical evaluation and microbiology of oropharyngeal infection due to fluconazole-resistant Candida in human immunodeficiency virus-infected patientsS G Revankar, O P Dib, W R Kirkpatrick, et al.
Antimicrobial Agents and Chemotherapy|September 15, 2001
Prevalence of molecular mechanisms of resistance to azole antifungal agents in Candida albicans strains displaying high-level fluconazole resistance isolated from human immunodeficiency virus-infected patientsS Perea, J L López-Ribot, W R Kirkpatrick, et al.
Medicine|August 15, 2000
Invasive aspergillosis. Disease spectrum, treatment practices, and outcomes. I3 Aspergillus Study GroupT F Patterson, W R Kirkpatrick, M White, et al.
The American Journal of Medicine|August 4, 1998
A randomized trial of continuous or intermittent therapy with fluconazole for oropharyngeal candidiasis in HIV-infected patients: clinical outcomes and development of fluconazole resistanceS G Revankar, W R Kirkpatrick, R K McAtee, et al.
Journal of Clinical Microbiology|November 24, 1999
Epidemiology of oropharyngeal Candida colonization and infection in patients receiving radiation for head and neck cancerS W Redding, R C Zellars, W R Kirkpatrick, et al.
Journal of Clinical Microbiology|September 17, 1998
Detection of Candida dubliniensis in oropharyngeal samples from human immunodeficiency virus-infected patients in North America by primary CHROMagar candida screening and susceptibility testing of isolatesW R Kirkpatrick, S G Revankar, R K Mcatee, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Journal of Clinical Microbiology|July 1, 1996
Simple method for detecting fluconazole-resistant yeasts with chromogenic agarT F Patterson, S G Revankar, W R Kirkpatrick, et al.
The Journal of Infectious Diseases|October 1, 1996
Detection and significance of fluconazole resistance in oropharyngeal candidiasis in human immunodeficiency virus-infected patientsS G Revankar, W R Kirkpatrick, R K McAtee, et al.
Journal of Clinical Microbiology|December 8, 2004
Comparison of antifungal susceptibilities to fluconazole and voriconazole of oral Candida glabrata isolates from head and neck radiation patientsA K Burn, A W Fothergill, W R Kirkpatrick, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 13, 1998
Clinical evaluation and microbiology of oropharyngeal infection due to fluconazole-resistant Candida in human immunodeficiency virus-infected patientsS G Revankar, O P Dib, W R Kirkpatrick, et al.
Antimicrobial Agents and Chemotherapy|September 15, 2001
Prevalence of molecular mechanisms of resistance to azole antifungal agents in Candida albicans strains displaying high-level fluconazole resistance isolated from human immunodeficiency virus-infected patientsS Perea, J L López-Ribot, W R Kirkpatrick, et al.
Medicine|August 15, 2000
Invasive aspergillosis. Disease spectrum, treatment practices, and outcomes. I3 Aspergillus Study GroupT F Patterson, W R Kirkpatrick, M White, et al.
The American Journal of Medicine|August 4, 1998
A randomized trial of continuous or intermittent therapy with fluconazole for oropharyngeal candidiasis in HIV-infected patients: clinical outcomes and development of fluconazole resistanceS G Revankar, W R Kirkpatrick, R K McAtee, et al.
Journal of Clinical Microbiology|November 24, 1999
Epidemiology of oropharyngeal Candida colonization and infection in patients receiving radiation for head and neck cancerS W Redding, R C Zellars, W R Kirkpatrick, et al.
Journal of Clinical Microbiology|September 17, 1998
Detection of Candida dubliniensis in oropharyngeal samples from human immunodeficiency virus-infected patients in North America by primary CHROMagar candida screening and susceptibility testing of isolatesW R Kirkpatrick, S G Revankar, R K Mcatee, et al.
Pageof 3